BioSpace News Archive

Novel Epigenomic Approach Provides Proof of Concept for Early Cancer Detection Paving the Way for Next-Generation Screening Tests

Case Study highlights how a Medicaid Plan now receives rebates from Biogen for patients who discontinued their treatment with Avonex® (interferon beta-1a) and Tecfidera® (dimethyl fumarate)

VivoSense, Inc. is proud to announce that we have been awarded an NIH/NCI Phase 1 contract to develop software enabling data integration from wearable sensors for cancer patients. The contract will result in the development of the VivoSense Cancer Health Informatics Platform as the leading wearable sensor agnostic cloud pl

TScan Therapeutics Announces Publication of Study in Immunity Highlighting the Discovery of Novel T Cell Targets in COVID-19 T-Scan platform discovered that T cells of COVID-19 patients recognize a core set of shared targets in SARS-CoV-2 and that most of these targets are not found in the Spike protein Identification of specific T cell targets enables development of next-generation vaccines, T cell-based diagnostics, and T cell therapies for COVID

ATMPS Ltd – a spinout of FarmaTrust announces that its Hataali blockchain platform has been successfully tested with University Hospitals Birmingham NHS Foundation Trust’s system interface.